Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research Units
Projects
Activities
Datasets
Equipment
Prizes
Press / Media
Search by expertise, name or affiliation
A Phase 1b Study of Eltromobopag and Azacitidine in Patients with High Risk Myelodysplastic Syndromes and Related Disorders (ELAstic)
Fenwick, Nicola
(Principal Investigator)
Cancer Clinical Trials Unit
Overview
Project Details
Short title
A Phase 1b Study of Eltromobopag and Azacitidine in Patients with High Risk Myelodysplastic Syndromes and Related Disorders (ELAstic)
Status
Finished
Effective start/end date
1/10/14
→
30/09/21
Funding
Glaxosmithkline
CELGENE INTERNATIONAL SARL
View all
View less